首页> 外文期刊>Blood: The Journal of the American Society of Hematology >IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functions
【24h】

IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functions

机译:IGHV未突变和IGHV突变的慢性淋巴细胞白血病细胞产生活化诱导的脱氨酶蛋白,具有全面的生物学功能

获取原文
获取原文并翻译 | 示例
           

摘要

Clonal evolution occurs during the course of chronic lymphocytic leukemia (CLL) and activation-induced deaminase (AID) could influence this process. However, this possibility has been questioned in CLL because the number of circulating AID mRNA(+) cells is exceedingly low; synthesis of AID protein by blood CLL cells has not been demonstrated; the full range of AID functions is lacking in unmutated CLL (U-CLL), and no prospective analysis linking AID expression and disease severity has been reported. The results of the present study show that circulating CLL cells and those within secondary lymphoid tissues can make AID mRNA and protein. This production is related to cell division because more AID mRNA was detected in recently divided cells and AID protein was limited to the dividing fraction and was up-regulated on induction of cell division. AID protein was functional because AID(+) dividing cells exhibited more double-stranded DNA breaks, IGH class switching, and new IGHV-D-J mutations. Each of these actions was documented in U-CLL and mutated CLL (M-CLL). Furthermore, AID protein was associated with worse patient outcome and adverse cytogenetics. We conclude that the production of fully functional AID protein by U-CLL and M-CLL cells could be involved in clonal evolution of the disease. (Blood. 2012;120(24):4802-4811)
机译:克隆进化发生在慢性淋巴细胞性白血病(CLL)的过程中,激活诱导的脱氨酶(AID)可能影响这一过程。但是,这种可能性在CLL中受到质疑,因为循环中的AID mRNA(+)细胞数量极少。尚未通过血液CLL细胞合成AID蛋白;未突变的CLL(U-CLL)缺乏完整的AID功能,也没有报道将AID表达与疾病严重程度联系起来的前瞻性分析。本研究的结果表明,循环的CLL细胞和继发性淋巴组织内的细胞可以产生AID mRNA和蛋白质。这种产生与细胞分裂有关,因为在最近分裂的细胞中检测到更多的AID mRNA,并且AID蛋白仅限于分裂部分,并在诱导细胞分裂时被上调。 AID蛋白之所以起作用,是因为AID(+)分裂细胞表现出更多的双链DNA断裂,IGH类转换和新的IGHV-D-J突变。这些操作中的每一个都记录在U-CLL和突变的CLL(M-CLL)中。此外,AID蛋白与患者预后不良和细胞遗传学不良有关。我们得出的结论是,由U-CLL和M-CLL细胞产生的功能齐全的AID蛋白可能与疾病的克隆进化有关。 (血液.2012; 120(24):4802-4811)

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号